Bioanalytical OverviewOne of the world’s largest offerings for bioanalysis of small molecules and biologics,

with state-of-the-art facilities in the USA, Europe, India and Taiwan

B I O A N A L Y T I C A L O V E R V I E W

G Y R O S

L C - I C P - M S L C - M S / M S

H Y B R I D I Z A T I O N - E L I S A

I C P - M S

E C L

E L I S A

Introduction to QPS’ Global Bioanalytical Services:

With four highly experienced bioanalytical sites established

in the USA, Netherlands, Taiwan and India, where QPS bio-

analytical scientists routinely develop and validate hundreds of

proprietary and non-proprietary bioanalytical methods

annually, QPS is a true global leader in bioanalytical services.

P E P T I D E S

O L I G O N U C L E O T I D E S

P R O T E I N S

G A D O L I N I U M

M O N O C L O N A L A N T I B O D I E S

P L A T I N U M

L A R G E & S M A L L M O L E C U L E

Find out how to achieve your next development milestone ahead of time. Call to schedule your tour at one of QPS’ worldwide locations today!

C L I N I C A L D R U G D E V E L O P M E N T

B I O A N A L Y T I C A L

P H A R M A C E U T I C A L

P R E C L I N I C A L

B I O T E C H N O L O G Y

T R A N S L A T I O N A L M E D I C I N E

G L O B A L C R O

D I S C O V E R Y

Q U A L I T Y S E R V I C E S

Why should QPS be your first and only choice to conduct your bioanalysis studies?

Direct Peer-to-Peer InteractionsWith QPS you get immediate access to a team of senior bioanalytical scientists that have superior scientific expertise in method feasibility, development, and validation and method transfer for all your bioanalytical sourcing needs across a broad range of compound structures and therapeutic targets. Nothing is more effective and stimulating for your bioanalytical scientists than to communicate directly with their peers at QPS to get science done. That is why all sponsors of QPS are served by highly experienced Study Directors.

Fast TurnaroundHistorical data has clearly demonstrated that the direction taken by drug discovery and development is substantially influenced by bioanalytical results. Our scientific experience, integrated services, capacity and application of the state-of-the-art bioanalytical equipment provides fast turn around that will help you to arrive at “go/no-go” decisions faster while reducing your total preclinical and clinical study costs.

Global Capacity and FlexibilityBenefit from QPS’ global resources of five main technology platforms consisting of a total of 50+ LC/MS/MS systems for small molecules, through polypeptides up to proteins; ELISA for proteins and vaccines; hybridization-ELISA for oligonucleotide-based drugs; radiochemical detection for human mass balance studies; and ECL for immunogenicity and multiplexing (e.g. biomarkers). In addition to these five major analytical techniques, a range of niche technologies ((LC)-ICP-MS, PGx, Gyros, Nephelometry) is available through which a portfolio of assay principles is offered to cover your entire demand in bioanalysis. Customer FocusQPS focuses on the needs of each client and works to make sure that those needs are met. We strive to make certain that your sample analysis is completed and reported on time. We also strive to ensure optimal communications so you have always complete visibility into your project’s status and can be rest assured that your deadlines will be met without compromising quality. At QPS, we measure our success by your success.

Preferred Provider Relationship: Improved Efficiency and Lower CostsImprove the efficiency and effectiveness of your drug development efforts and qualify for volume discounts by embracing QPS as your preferred provider for all your bioanalytical sourcing needs. You will be assigned a dedicated program manager to handle all your sample analysis and enjoy maximum benefit of our leveraged strengths of doing different types of (niche) analysis at distinct bioanalytical sites in order to keep your overall research development costs as low as possible. QPS’ laboratory sites in Delaware, USA, Netherlands, Taiwan and India perform work under GLP.

QPS offers a full range of Bioanalytical services including:

Small Molecule LC-MS/MS: Analytical Method Development & Validation Sample Analysis Dried Blood Spots

Large Molecule ImmunoBioanalysis: Analytical Method Development & Validation- Oligonucleotides- Peptides- Proteins- Monoclonal Antibodies

Sample Analysis Immunogenicity studies using four-tier approach- Screening- Confirmatory (immunodepletion)- Titer assessment (quantification)- Cell-based neutralizing antibody detection

Large Molecule LC-MS/MS: Analytical Method Development & Validation- Oligonucleotides- Peptides- Proteins- Monoclonal Antibodies

Sample Analysis

Element (LC-)ICP-MS: Analytical Method Development & Validation Sample Analysis- Platinum- Gadolinium- Iron- Magnesium- Non-Metal Elements (i.e. I, Br, S)

I N N O V A T I O N

P A S S I O N A T E

P R O D U C T I V E

B E N E F I T P A T I E N T S

12

34

1 QPS|Delaware 2 QPS|Netherlands 3 QPS|India 4 QPS|Taiwan

Call to arrange for a tour at one of QPS’ worldwide bioanalysis laboratories today

Time is of the essence

in drug development,

so contact a member

of the QPS Business

Development Team today

and find out what QPS

can do for you.

HQ BD Office Lily Rosa (USA)

+1 512 350 2827 info@qps.com

Company Values: Integrity - We make and keep promises and build trust through honesty, proactive communication and reliability - Quality - We bring the highest level of technical expertise and judgement to our work - Customer Focus - We tap our global resources to provide service that is fast, flexible and integrated - Commitment - We work hard to solve problems and deliver results - People - We treat people with dignity, respect and fairness, and embrace our differences - Culture - We are friendly and fun. We provide opportunities to grow, we value loyalty and teamwork, and we recognize and reward performance.